Ra Pharmaceuticals Signs Merck Deal for Up to $200M

By Bernadette Tansey

Apr 02, 2013


Cambridge, MA-based Ra Pharmaceuticals has signed a collaboration deal with drug giant Merck that could provide the small company with as much as $200 million to support the development of its stable of novel drug candidates. Read the full story
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments